← Back to Search
SCORING THE SHORT FORM ICSmaleSF QUESTIONNAIRE
J. Donovan, T. Peters, P. Abrams, S. Brookes, J. Rosette, W. Schaefer
Published 2000 · Medicine
Download PDFAnalyze on Scholarcy
Purpose: The International Continence Society (ICS) ICSmale questionnaire was devised to provide a thorough evaluation of the occurrence and bothersomeness of lower urinary tract symptoms and their impact on the lives of men with benign prostatic disease. This report completes the developmental work on the questionnaire, producing the concise short form instrument, ICSmaleSF, with a valid, reliable and scientifically justified scoring system.Materials and Methods: Two data sets were used. The short form version of the questionnaire was devised and initially evaluated using data on men with uncomplicated lower urinary tract symptoms who were involved in the CLasP randomized controlled trial comparing laser therapy with transurethral prostatic resection and conservative management or monitoring without active intervention. External validation of the scoring system was undertaken using data from phase II of the ICS benign prostatic hyperplasia (BPH) study, an observational study of outcome in men with lower ...
This paper references
THE AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA
M. Barry (2017)
Distinction between symptoms of voiding and filling in benign prostatic hyperplasia: findings from the Health Professionals Follow-up Study.
G. Welch (1998)
Bladder compliance in patients with benign prostatic hyperplasia
P. Abrams (1997)
Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age.
H. Lepor (1993)
Validation of the self-administered Danish Prostatic Symptom Score (DAN-PSS-1) system for use in benign prostatic hyperplasia.
B. J. Hansen (1995)
A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study.
J. Donovan (2000)
Similarity of the American Urological Association Symptom Index among men with benign prostate hyperplasia (BPH), urethral obstruction not due to BPH and detrusor hyperreflexia without outlet obstruction.
M. Chancellor (1994)
The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.
M. Barry (1992)
A patient weighted symptom score system in the evaluation of uncomplicated benign prostatic hyperplasia.
T. Hald (1991)
Relationships between lower urinary tract symptoms and bladder outlet obstruction: Results from the ICS‐“BPH” Study
J. de la Rosette (1998)
The ICS-'BPH' Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction.
J. Reynard (1998)
Sexual dysfunction in men with lower urinary tract symptoms.
S. Frankel (1998)
A new patient weighted symptom score system (DAN-PSS-1). Clinical assessment of indications and outcomes of transurethral prostatectomy for uncomplicated benign prostatic hyperplasia.
H. Meyhoff (1993)
International Continence Society "Benign Prostatic Hyperplasia" Study: background, aims, and methodology.
P. Abrams (1997)
Using the ICSQoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS–‘BPH’ study
J. Donovan (1997)
American Urological Association symptom index for women with voiding symptoms: lack of index specificity for benign prostate hyperplasia.
M. Chancellor (1993)
The International Continence Society "Benign Prostatic Hyperplasia" Study: the botherosomeness of urinary symptoms.
T. Peters (1997)
The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire.
J. Donovan (1996)
This paper is referenced by
Recommandations pour l’utilisation du calendrier mictionnel et des questionnaires de symptômes ou de qualité de vie dans l’évaluation d’une incontinence urinaire féminine non neurologique
L. L. Normand (2008)
Psychological distress and prostate specific antigen levels in men with and without prostate cancer
E. Turner (2009)
Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments
A. Lane (2016)
Clinical experiences with desmopressin for long-term treatment of nocturia.
G. Lose (2004)
Abklärung der Harninkontinenz
M. Kurz (2014)
Urodynamic interpretation of changing bladder function and voiding pattern after radical prostatectomy: a long‐term follow‐up
Cheryn Song (2010)
ProDiet: A Phase II Randomized Placebo-controlled Trial of Green Tea Catechins and Lycopene in Men at Increased Risk of Prostate Cancer
J. Lane (2018)
Evaluation of quality of life after laparoscopic surgery
D. Korolija (2004)
The EAES Clinical Practice Guidelines on the Evaluation of Quality of Life After Laparoscopic Surgery (2004)
D. Korolija (2006)
Quality of life assessment for patients with urinary incontinence.
M. Gotoh (2007)
Initial assessment of urinary and faecal incontinence in adult male and female patients
D. Staskin (2009)
Lower Urinary Tract Symptoms in Adults: A Clinical Approach
M. Drake (2020)
[Comparison of IPSS and ICS male SF in the initial assessment of urinary disorders].
P. Perrin (2008)
Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial.
M. Barry (2011)
Factors associated with trial recruitment, preferences and treatments received were elucidated in a comprehensive-cohort study.
J. Donovan (2019)
EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
C. Gratzke (2015)
Urgency and other lower urinary tract symptoms in men aged ≥ 40 years: a Belgian epidemiological survey using the ICIQ‐MLUTS questionnaire
D. de Ridder (2015)
ICIQ: A brief and robust measure for evaluating the symptoms and impact of urinary incontinence
K. Avery (2004)
Symptom severity and QOL scales for urinary incontinence.
M. Naughton (2004)
Holmium laser enucleation of the prostate: results at 6 years.
P. Gilling (2008)
TAKE HOME MESSAGE Platinum Priority – Review – Benign Prostatic Obstruction
Validity and reliability of a questionnaire to measure the impact of lower urinary tract symptoms on quality of life: The Leicester impact scale
C. Shaw (2004)
Fourth international consultation on incontinence recommendations of the international scientific committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence
P. Abrams (2010)
Cross-Cultural Adaptation and Validation of the Serbian Version of the ICS SF Male Questionnaire
U. Babić (2015)
What questionnaires to use when measuring quality of life in sacral tumor patients: the updated sacral tumor survey.
Olivier D R van Wulfften Palthe (2017)
Tumour characteristics, oncological and functional outcomes in patients aged ≥ 70 years undergoing radical prostatectomy
I. Kunz (2013)
Health-related quality of life among long-term (≥5 years) prostate cancer survivors by primary intervention: a systematic review
S. Adam (2018)
A Review of Scales to Evaluate Sleep Disturbances in Movement Disorders
M. Kurtis (2018)
Feasibility, technique, and principles of tension- and energy-free laparoscopic radical prostatectomy with lateral intrafascial dissection of the neurovascular bundles with the use of a high-definition optical device.
S. Cusumano (2008)
Prevalence, Risk Factors and Bother Associated withLower Urinary Tract Symptoms among Young Adults in Al-Qassim, Saudi Arabia
Ali Mahmoud Alzammam (2017)
Patient reported outcomes: The ICIQ and the state of the art
K. Coyne (2010)
Associations of lower urinary tract symptoms with prostate‐specific antigen levels, and screen‐detected localized and advanced prostate cancer: a case‐control study nested within the UK population‐based ProtecT (Prostate testing for cancer and Treatment) study
S. Collin (2008)See more